Eisai Co (ESAIY)

Currency in USD
6.63
+0.06(+0.91%)
Closed·
High dividend Yield
ESAIY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.586.63
52 wk Range
5.699.22
Key Statistics
Prev. Close
6.57
Open
6.62
Day's Range
6.58-6.63
52 wk Range
5.69-9.22
Volume
129.97K
Average Volume (3m)
218.27K
1-Year Change
-1.4859%
Book Value / Share
20.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ESAIY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Eisai Co News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-11.53 / --
Revenue / Forecast
205.43B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 136.78%
Dividend Yield
16.21%
Industry Median 2.41%
Annualized payout
1.07
Paid unevenly
5-Years Growth
-
Growth Streak

ESAIY Income Statement

Compare ESAIY to Peers and Sector

Metrics to compare
ESAIY
Peers
Sector
Relationship
P/E Ratio
31.4x20.5x−0.4x
PEG Ratio
−0.510.310.00
Price/Book
1.3x1.5x2.6x
Price / LTM Sales
1.5x2.3x3.0x
Upside (Analyst Target)
-22.7%51.7%
Fair Value Upside
Unlock10.2%8.8%Unlock

Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments. It offers Lenvima, a multi-kinase inhibitor which is involved in tumor angiogenesis or tumor malignancy; LEQEMBI, a humanized IgG1 monoclonal antibody against amyloid-beta (Aß) protofibrils; and Dayvigo, a novel small molecule compound. The company also provides prescription drugs; and over-the-counter drugs, as well as focuses on neurology and oncology, and other therapeutic areas. It operates in Europe, the Middle East, Africa, Russia, Oceania, the Americas, China, East Asia, the Global South, and internationally. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Employees
10543

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
106.44M37.71%2.66B
Other Institutional Investors
46.18M16.36%1.15B
Public Companies & Retail Investors
129.62M45.93%3.24B
Total
282.24M100.00%7.06B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.52%24,036,592600,915
Nomura Asset Management Co., Ltd.7.53%21,252,800531,320

FAQ

What Is the Eisai Co (ESAIY) Stock Price Today?

The Eisai Co stock price today is 6.63 USD.

What Stock Exchange Does Eisai Co Trade On?

Eisai Co is listed and trades on the OTC Markets.

What Is the Stock Symbol for Eisai Co?

The stock symbol for Eisai Co is "ESAIY."

Does Eisai Co Pay Dividends? What’s The Current Dividend Yield?

The Eisai Co dividend yield is 16.21%.

What Is the Eisai Co Market Cap?

As of today, Eisai Co market cap is 7.50B USD.

What Is Eisai Co's Earnings Per Share (TTM)?

The Eisai Co EPS (TTM) is 136.78.

From a Technical Analysis Perspective, Is ESAIY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Eisai Co Stock Split?

Eisai Co has split 2 times.

How Many Employees Does Eisai Co Have?

Eisai Co has 10543 employees.

What is the current trading status of Eisai Co (ESAIY)?

As of Jul 12, 2026, Eisai Co (ESAIY) is trading at a price of 6.63 USD, with a previous close of 6.57 USD. The stock has fluctuated within a day range of 6.58 USD to 6.63 USD, while its 52-week range spans from 5.69 USD to 9.22 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.